Authors: Sharon Salt, Editor
Earlier this week, Japan’s health ministry approved the world’s first clinical trial for the treatment of spinal cord injuries using induced pluripotent stem cells (iPS), according to a report from The Japan Times.
Restricted Content / Members Only
Restricted Content / Members Only